Replenishable drug depot to combat post-resection cancer recurrence

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Bioorthogonal Chemistry

Background:

• Local drug delivery via depots offers therapeutic benefits but current systems are single-use and non-refillable.
• Implantation at inaccessible sites limits the clinical utility of traditional drug-eluting depots.
• Noninvasive refilling strategies are needed to enhance the application of drug-eluting depots.

Purpose of the Study:

• To develop a novel, refillable hydrogel depot system utilizing bioorthogonal click chemistry.
• To demonstrate the capacity for noninvasive refilling of drug depots from systemically administered refills.
• To evaluate the efficacy of refillable depots for sustained local drug release in a cancer model.

Main Methods:

• Fabrication of hydrogel depots modified with bioorthogonal click chemistry components.
• Systemic administration of prodrug refills designed to be captured by the hydrogel depots.
• In vivo evaluation of depot refilling, sustained drug release, and therapeutic effects at tumor sites.

Main Results:

• The developed hydrogel depots successfully captured systemically administered prodrug refills via click chemistry.
• The refillable depots provided sustained local release of active drugs at precancerous tumor sites.
• The system demonstrated potential for repeated refilling, offering a non-toxic method to enhance drug delivery.

Conclusions:

• A refillable hydrogel depot system based on bioorthogonal click chemistry was successfully developed.
• This technology enables noninvasive, repeated refilling for sustained local drug delivery, overcoming limitations of single-use depots.
• Refillable depots hold significant promise for improving localized therapies, particularly in cancer treatment, and other medical applications.